108 related articles for article (PubMed ID: 8295810)
1. Overview of the pharmacology of clarithromycin suspension in children and a comparison with that in adults.
Guay DR; Craft JC
Pediatr Infect Dis J; 1993 Dec; 12(12 Suppl 3):S106-11. PubMed ID: 8295810
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of a clarithromycin suspension in infants and children.
Gan VN; Chu SY; Kusmiesz HT; Craft JC
Antimicrob Agents Chemother; 1992 Nov; 36(11):2478-80. PubMed ID: 1489191
[TBL] [Abstract][Full Text] [Related]
3. Penetration of clarithromycin into middle ear fluid of children with acute otitis media.
Gan VN; McCarty JM; Chu SY; Carr R
Pediatr Infect Dis J; 1997 Jan; 16(1):39-43. PubMed ID: 9002099
[TBL] [Abstract][Full Text] [Related]
4. Clarithromycin vs. amoxicillin suspensions in the treatment of pediatric patients with acute otitis media.
Pukander JS; Jero JP; Kaprio EA; Sorri MJ
Pediatr Infect Dis J; 1993 Dec; 12(12 Suppl 3):S118-21. PubMed ID: 8295812
[TBL] [Abstract][Full Text] [Related]
5. Relative bioavailability and effects of a high fat meal on single dose cilostazol pharmacokinetics.
Bramer SL; Forbes WP
Clin Pharmacokinet; 1999; 37 Suppl 2():13-23. PubMed ID: 10702883
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and comparative bioavailability study of two clarithromycin suspensions following administration of a single oral dose to healthy volunteers.
Zakeri-Milani P; Valizadeh H; Ghanbarzadeh S; Nemati M
Arzneimittelforschung; 2009; 59(8):429-32. PubMed ID: 19813467
[TBL] [Abstract][Full Text] [Related]
7. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
[TBL] [Abstract][Full Text] [Related]
9. Penetration of clarithromycin and its 14-hydroxy metabolite into middle ear effusion in children with secretory otitis media.
Sundberg L; Cederberg A
J Antimicrob Chemother; 1994 Feb; 33(2):299-307. PubMed ID: 8182011
[TBL] [Abstract][Full Text] [Related]
10. Single- and multiple-dose pharmacokinetics of clarithromycin, a new macrolide antimicrobial.
Chu S; Wilson DS; Deaton RL; Mackenthun AV; Eason CN; Cavanaugh JH
J Clin Pharmacol; 1993 Aug; 33(8):719-26. PubMed ID: 8408732
[TBL] [Abstract][Full Text] [Related]
11. Clarithromycin and cefaclor suspensions in the treatment of acute otitis media in children.
Gooch WM; Gan VN; Corder WT; Khurana CM; Andrews WP
Pediatr Infect Dis J; 1993 Dec; 12(12 Suppl 3):S128-33. PubMed ID: 8295814
[TBL] [Abstract][Full Text] [Related]
12. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
[TBL] [Abstract][Full Text] [Related]
13. Drug-food interaction potential of clarithromycin, a new macrolide antimicrobial.
Chu S; Park Y; Locke C; Wilson DS; Cavanaugh JC
J Clin Pharmacol; 1992 Jan; 32(1):32-6. PubMed ID: 1531484
[TBL] [Abstract][Full Text] [Related]
14. Comparative safety and efficacy of clarithromycin and cefadroxil suspensions in the treatment of mild to moderate skin and skin structure infections in children.
Hebert AA; Still JG; Reuman PD
Pediatr Infect Dis J; 1993 Dec; 12(12 Suppl 3):S112-7. PubMed ID: 8295811
[TBL] [Abstract][Full Text] [Related]
15. Oral bioequivalence of three ciprofloxacin formulations following single-dose administration: 500 mg tablet compared with 500 mg/10 mL or 500 mg/5 mL suspension and the effect of food on the absorption of ciprofloxacin oral suspension.
Shah A; Liu MC; Vaughan D; Heller AH
J Antimicrob Chemother; 1999 Mar; 43 Suppl A():49-54. PubMed ID: 10225572
[TBL] [Abstract][Full Text] [Related]
16. Clarithromycin pharmacokinetics in healthy young and elderly volunteers.
Chu SY; Wilson DS; Guay DR; Craft C
J Clin Pharmacol; 1992 Nov; 32(11):1045-9. PubMed ID: 1474166
[TBL] [Abstract][Full Text] [Related]
17. Clarithromycin suspension: bioequivalence studies on two different strengths.
Koytchev R; Ozalp Y; Erenmemisoglu A; van der Meer MJ; Alpan RS
Arzneimittelforschung; 2004 Sep; 54(9A):594-9. PubMed ID: 15497666
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic interaction between ritonavir and clarithromycin.
Ouellet D; Hsu A; Granneman GR; Carlson G; Cavanaugh J; Guenther H; Leonard JM
Clin Pharmacol Ther; 1998 Oct; 64(4):355-62. PubMed ID: 9797791
[TBL] [Abstract][Full Text] [Related]
19. Clarithromycin clinical pharmacokinetics.
Fraschini F; Scaglione F; Demartini G
Clin Pharmacokinet; 1993 Sep; 25(3):189-204. PubMed ID: 8222460
[TBL] [Abstract][Full Text] [Related]
20. Modeling the autoinhibition of clarithromycin metabolism during repeated oral administration.
Abduljalil K; Kinzig M; Bulitta J; Horkovics-Kovats S; Sörgel F; Rodamer M; Fuhr U
Antimicrob Agents Chemother; 2009 Jul; 53(7):2892-901. PubMed ID: 19414584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
